keyword
https://read.qxmd.com/read/38025266/whole-exome-sequencing-of-patients-with-varicella-zoster-virus-and-herpes-simplex-virus-induced-acute-retinal-necrosis-reveals-rare-disease-associated-genetic-variants
#1
JOURNAL ARTICLE
Johanna L Heinz, Sigrid M A Swagemakers, Joanna von Hofsten, Marie Helleberg, Michelle M Thomsen, Kerstin De Keukeleere, Joke H de Boer, Tomas Ilginis, Georges M G M Verjans, Peter M van Hagen, Peter J van der Spek, Trine H Mogensen
PURPOSE: Herpes simplex virus (HSV) and varicella-zoster virus (VZV) are neurotropic human alphaherpesviruses endemic worldwide. Upon primary infection, both viruses establish lifelong latency in neurons and reactivate intermittently to cause a variety of mild to severe diseases. Acute retinal necrosis (ARN) is a rare, sight-threatening eye disease induced by ocular VZV or HSV infection. The virus and host factors involved in ARN pathogenesis remain incompletely described. We hypothesize an underlying genetic defect in at least part of ARN cases...
2023: Frontiers in Molecular Neuroscience
https://read.qxmd.com/read/37999770/cerebrospinal-fluid-findings-in-patients-with-neurological-manifestations-in-post-covid-19-syndrome
#2
JOURNAL ARTICLE
Fabian Boesl, Yasemin Goereci, Ameli Gerhard, Benno Bremer, Vanessa Raeder, Finja Schweitzer, Uta Hoppmann, Janina Behrens, Judith Bellmann-Strobl, Friedemann Paul, Brigitte Wildemann, Sven Jarius, Harald Prüss, Heinrich J Audebert, Clemens Warnke, Christiana Franke
BACKGROUND: Information on cerebrospinal fluid (CSF) findings in patients with neurological manifestations in post-COVID-19 syndrome is scarce. METHODS: Retrospective evaluation of 84 CSF samples in patients fulfilling post-COVID-19 criteria in two neurological post-COVID-19 outpatient clinics. RESULTS: In 68% of samples, all CSF parameters were normal. The most frequent pathological CSF finding was elevation of total protein (median total protein 33...
January 2024: Journal of Neurology
https://read.qxmd.com/read/37515229/hyperimmune-globulins-for-the-management-of-infectious-diseases
#3
REVIEW
Ilaria Pati, Mario Cruciani, Fabio Candura, Maria Simona Massari, Vanessa Piccinini, Francesca Masiello, Samantha Profili, Lucia De Fulvio, Simonetta Pupella, Vincenzo De Angelis
This review is focused on the use of hyperimmune globulin therapy to treat some infectious diseases of viral or bacterial origin. Despite the introduction of antibiotics and vaccines, plasma immunoglobulin therapy from whole blood donation can still play a key role. These treatments provide passive transfer of high-titer antibodies that either reduces the risk or the severity of the infection and offer immediate but short-term protection against specific diseases. Antibody preparations derived from immunized human donors are commonly used for the prophylaxis and treatment of rabies, hepatitis A and B viruses, varicella-zoster virus, and pneumonia caused by respiratory syncytial virus, Clostridium tetani , Clostridium botulinum ...
July 13, 2023: Viruses
https://read.qxmd.com/read/37465673/prediction-of-herpes-virus-infections-after-solid-organ-transplantation-a-prospective-study-of-immune-function
#4
JOURNAL ARTICLE
Dina Leth Møller, Søren Schwartz Sørensen, Omid Rezahosseini, Daniel Bräuner Rasmussen, Nicoline Stender Arentoft, Josefine Amalie Loft, Michael Perch, Finn Gustafsson, Jens Lundgren, Thomas Scheike, Jenny Dahl Knudsen, Sisse Rye Ostrowski, Allan Rasmussen, Susanne Dam Nielsen
INTRODUCTION: Herpes virus infections are a major concern after solid organ transplantation and linked to the immune function of the recipient. We aimed to determine the incidence of positive herpes virus (cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus type 1/2 (HSV-1/2), and varicella zoster virus (VZV)) PCR tests during the first year post-transplantation and assess whether a model including immune function pre-transplantation and three months post-transplantation could predict a subsequent positive herpes virus PCR...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37306550/risk-of-a-first-clinical-diagnosis-of-cns-demyelination-in-relation-to-human-herpesviruses-in-the-context-of-epstein-barr-virus
#5
JOURNAL ARTICLE
Robyn M Lucas, M-L J Lay, James Grant, Nicolas Cherbuin, Cheryl S Toi, Keith Dear, Bruce V Taylor, Dominic E Dwyer, Anne-Louise Ponsonby
BACKGROUND: Epstein-Barr virus (EBV) is implicated in MS risk; evidence for other herpesviruses is inconsistent. Here we test blood markers of infection with Human herpesvirus 6 (HHV-6), varicella-zoster virus (VZV) and cytomegalovirus (CMV), as risk factors for a first clinical diagnosis of CNS demyelination (FCD) in the context of markers of EBV infection. METHODS: In the Ausimmune case-control study, cases had a FCD and population controls were matched on age, sex and study region...
June 12, 2023: European Journal of Neurology
https://read.qxmd.com/read/36690067/rapid-sensitive-and-specific-lateral-flow-immunochromatographic-point-of-care-device-for-detection-of-varicella-zoster-virus-immunoglobulin-g-antibodies-in-fingerstick-blood
#6
JOURNAL ARTICLE
Nicholas Vafai, Kevin Self, Bret Sheffield, Sally Hojvat, Aubrey Kusi-Appiah, Patrick Vaughan, Elliot Cowan, Abbas Vafai
Varicella zoster virus (VZV) causes childhood chickenpox, becomes latent in sensory ganglia and reactivates years later to cause shingles (Zoster) and postherpetic neuralgia in the elderly and immunosuppressed individuals. Serologic IgG tests can be used to determine if a person has antibodies to VZV from past varicella infection or had received varicella or zoster (shingles) vaccination. Commercial enzyme-linked immunosorbent assays (ELISAs) are currently used for the detection of VZV IgG antibodies in patient serum samples...
January 20, 2023: Journal of Immunological Methods
https://read.qxmd.com/read/36603329/evaluation-and-clinical-validation-of-monkeypox-mpox-virus-real-time-pcr-assays
#7
JOURNAL ARTICLE
Margaret G Mills, Kate B Juergens, Jolene P Gov, Carter J McCormick, Reigran Sampoleo, Alisa Kachikis, John K Amory, Ferric C Fang, Ailyn C Pérez-Osorio, Nicole A P Lieberman, Alexander L Greninger
BACKGROUND: In spring of 2022, an outbreak of monkeypox (mpox) spread worldwide. Here, we describe performance characteristics of monkeypox virus (MPXV)-specific and pan-orthopoxvirus qPCR assays for clinical use. METHODS: We validated probe-based qPCR assays targeting MPXV-specific loci F3L and G2R (genes MPXVgp052/OPG065 and MPXVgp002 and gp190/OPG002, respectively) and a pan-orthopoxvirus assay targeting the E9L locus (MPXVgp057/OPG071). Clinical samples and synthetic controls were extracted using the Roche MP96 or Promega Maxwell 48 instrument...
December 23, 2022: Journal of Clinical Virology
https://read.qxmd.com/read/36300166/the-viral-load-of-human-cytomegalovirus-infection-in-children-following-hematopoietic-stem-cell-transplant-by-chip-digital-pcr
#8
JOURNAL ARTICLE
Wen-Jun Wang, Miao Feng, Feng He, Juan Song, Qin-Qin Song, Dong Xia, Rong Liu, Hai-Lan Yao, Jun Han
Objective: To detect viral load in human cytomegalovirus (HCMV) infection children after hematopoietic stem cell transplant (HSCT) by chip digital PCR (cdPCR). Methods: The plasmid pUC57-UL83 containing the HCMV-UL83 gene and HCMV AD169 strain were used to evaluate the sensitivity of cdPCR. Either HSV-1, HSV-2, VZV, EBV, HHV-6, or HHV-7 was used to evaluate the specificity of HCMV cdPCR. The cdPCR was compared with quantitative PCR (qPCR) by detecting HCMV infection in 125 children's whole blood samples following HSCT...
2022: Canadian Journal of Infectious Diseases & Medical Microbiology
https://read.qxmd.com/read/35967359/a-simple-to-perform-ifn-%C3%AE-mrna-gene-expression-assay-on-whole-blood-accurately-appraises-varicella-zoster-virus-specific-cell-mediated-immunity-after-allogeneic-hematopoietic-stem-cell-transplantation
#9
JOURNAL ARTICLE
Mathilde Boccard, Anne Conrad, William Mouton, Florent Valour, Chantal Roure-Sobas, Emilie Frobert, Barbara Rohmer, Vincent Alcazer, Hélène Labussière-Wallet, Hervé Ghesquières, Fabienne Venet, Karen Brengel-Pesce, Sophie Trouillet-Assant, Florence Ader
Herpes zoster, which is due to the reactivation of Varicella zoster virus (VZV), is a leading cause of morbidity after allogeneic hematopoietic stem cell transplantation (allo-HSCT). While cell-mediated immunity (CMI) is critical to inhibiting VZV reactivation, CMI is not routinely assessed due to a lack of reliable tests. In this study, we aimed to evaluate VZV-specific CMI among allo-HSCT recipients (n = 60) and healthy individuals (HI, n = 17) through a panel of three immune functional assays after ex vivo stimulation by VZV antigen: quantification of (i) IFN-γ release in the supernatants, (ii) T-cell proliferation after a 7-day stimulation of peripheral blood mononuclear cells (PBMC), and (iii) measurement of the ifn - γ mRNA gene expression level after 24 h of stimulation of a whole-blood sample...
2022: Frontiers in Immunology
https://read.qxmd.com/read/35632565/cellular-immune-response-after-vaccination-with-an-adjuvanted-recombinant-zoster-vaccine-in-allogeneic-hematopoietic-stem-cell-transplant-recipients
#10
JOURNAL ARTICLE
Michael Koldehoff, Peter A Horn, Monika Lindemann
Hematopoietic stem cell transplant (HSCT) recipients have a high risk of developing primary varicella-zoster virus (VZV) infection and reactivation. VZV vaccination may prevent infection and reactivation. In the current study, recipients of allogeneic HSCT (34 females, 45 males) were vaccinated with adjuvanted, recombinant zoster vaccine Shingrix™, which contains the VZV glycoprotein E. Cellular immunity against various VZV antigens was analyzed by interferon-gamma ELISpot. Peripheral blood mononuclear cells (PBMC) of recipients with versus without prior shingles (n = 36 and n = 43, respectively) showed approximately twofold higher VZV-specific responses prior to and post vaccination...
May 20, 2022: Vaccines
https://read.qxmd.com/read/35500358/lack-of-association-between-seropositivity-of-vasculopathy-related-viruses-and-moyamoya-disease
#11
JOURNAL ARTICLE
Yasuhisa Nakamura, Yohei Mineharu, Takahiko Kamata, Takeshi Funaki, Susumu Miyamoto, Akio Koizumi, Kouji H Harada
OBJECTIVES: Although the association between genetic factors, such as RNF213 mutations, and moyamoya disease (MMD) has been well investigated, environmental factors are largely undetermined. Thus, we aimed to examine whether viral infection increases the risk of MMD. MATERIALS AND METHODS: To eliminate the effect of presence or absence of the RNF213 p.R4810K mutation, the entire study population was positive for this mutation. We collected whole blood from 111 patients with MMD (45 familial and 66 sporadic cases) and 67 healthy volunteers, and we measured the immunoglobulin G titer of 11 viruses (cytomegalovirus, varicella-zoster virus, measles virus, rubella virus, herpes simplex virus, mumps virus, Epstein-Barr virus, human parvovirus B19, human herpesvirus 6 [HHV6], human herpesvirus 8, and John Cunningham virus) that were presumed to be associated with vasculopathy using the enzyme-linked immunosorbent assay...
July 2022: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://read.qxmd.com/read/31889148/characterization-of-potential-biomarkers-of-reactogenicity-of-licensed-antiviral-vaccines-randomized-controlled-clinical-trials-conducted-by-the-biovacsafe-consortium
#12
JOURNAL ARTICLE
January Weiner, David J M Lewis, Jeroen Maertzdorf, Hans-Joachim Mollenkopf, Caroline Bodinham, Kat Pizzoferro, Catherine Linley, Aldona Greenwood, Alberto Mantovani, Barbara Bottazzi, Philippe Denoel, Geert Leroux-Roels, Kent E Kester, Ingileif Jonsdottir, Robert van den Berg, Stefan H E Kaufmann, Giuseppe Del Giudice
Biomarkers predictive of inflammatory events post-vaccination could accelerate vaccine development. Within the BIOVACSAFE framework, we conducted three identically designed, placebo-controlled inpatient/outpatient clinical studies (NCT01765413/NCT01771354/NCT01771367). Six antiviral vaccination strategies were evaluated to generate training data-sets of pre-/post-vaccination vital signs, blood changes and whole-blood gene transcripts, and to identify putative biomarkers of early inflammation/reactogenicity that could guide the design of subsequent focused confirmatory studies...
December 30, 2019: Scientific Reports
https://read.qxmd.com/read/31358406/quantification-of-a-cell-mediated-immune-response-against-varicella-zoster-virus-by-assessing-responder-cd4-high-memory-cell-proliferation-in-activated-whole-blood-cultures
#13
JOURNAL ARTICLE
Ahmad M Haredy, Michihiro Takei, Shin-Ichi Iwamoto, Masafumi Ohno, Mitsuyo Kosaka, Kazue Hirota, Ritsuko Koketsu, Toshiomi Okuno, Kazuyoshi Ikuta, Koichi Yamanishi, Hirotaka Ebina
BACKGROUND: Herpes zoster (HZ) is caused by reactivation of a latent varicella zoster virus (VZV). The potential to develop HZ increases with age due to waning of memory cell-mediated immunity (CMI), mainly the CD4 response. Therefore, VZV-CD4-memory T cells (CD4-M) count in blood could serve as a barometer for HZ protection. However, direct quantification of these cells is known to be difficult because they are few in number in the blood. We thus developed a method to measure the proliferation level of CD4-M cells responding to VZV antigen in whole blood culture...
August 23, 2019: Vaccine
https://read.qxmd.com/read/30613990/evaluation-of-vzv-specific-cell-mediated-immunity-by-interferon-gamma-elisa-in-adults-%C3%A2-50-years-of-age-administered-a-herpes-zoster-vaccine
#14
JOURNAL ARTICLE
Ping Yang, Zhen Chen, Jieqiong Zhang, Wei Li, Changlin Zhu, Ping Qiu, Yaru Quan, Xiaoyu Cui, Liyong Yuan, Chunlai Jiang
Varicella-zoster virus (VZV)-specific cell-mediated immunity (CMI) is critical for preventing and controlling the onset of herpes zoster (HZ). To assess VZV CMI, an interferon-gamma (IFN-γ) enzyme-linked immunosorbent assay (ELISA) was validated by examining the influence of VZV-specific antigen content, incubation time, and interval from whole blood collection on the assay. In the phase II clinical trial, VZV-specific CMI in adults ≥50 years of age administered an HZ vaccine were evaluated by IFN-γ ELISA, as determined by measuring IFN-γ production in the whole blood in response to stimulation with ultraviolet light-inactivated VZV...
January 4, 2019: Journal of Medical Virology
https://read.qxmd.com/read/30567124/varicella-zoster-in-sudden-infant-death
#15
JOURNAL ARTICLE
Stéphane Dauger, Jerome Le Goff, Anna Deho, Peter Jones
A 2-month-old girl with normal development and no previous physical illnesses was resuscitated having been found lifeless on her back at home. On admission to Paediatric Intensive Care, she had severe metabolic disturbance, associated with an extremely troubling neurological signs. She died 2 hours later. A full body CT scan did not reveal injury and her parents declined an autopsy. Peripheral blood and cerebrospinal fluid samples were sterile. However, a broad-range PCR coupled with electrospray-ionisation mass spectrometry onto the PLEX-ID automat of peripheral blood revealed the presence of varicella zoster virus...
November 28, 2018: BMJ Case Reports
https://read.qxmd.com/read/30211253/varicella-zoster-virus-cns-vasculitis-and-rna-polymerase-iii-gene-mutation-in-identical-twins
#16
JOURNAL ARTICLE
Madalina E Carter-Timofte, Anders F Hansen, Maibritt Mardahl, Sébastien Fribourg, Franck Rapaport, Shen-Ying Zhang, Jean-Laurent Casanova, Søren R Paludan, Mette Christiansen, Carsten S Larsen, Trine H Mogensen
Objective: Deficiency in the cytosolic DNA sensor RNA Polymerase III (POL III) was recently described in children with severe varicella-zoster virus (VZV) infection in the CNS or lungs. Here, we describe a pair of monozygotic female twins, who both experienced severe recurrent CNS vasculitis caused by VZV reactivation. The clinical presentation and findings included recurrent episodes of headache, dizziness, and neurologic deficits, CSF with pleocytosis and intrathecal VZV antibody production, and MRI of the brain showing ischemic lesions...
November 2018: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/29410671/age-dependent-pre-vaccination-immunity-affects-the-immunogenicity-of-varicella-zoster-vaccination-in-middle-aged-adults
#17
JOURNAL ARTICLE
Marieke van der Heiden, Lia G H de Rond, Menno C van Zelm, Guy A M Berbers, Annemieke M H Boots, Anne-Marie Buisman
Background: Prevention of infectious diseases is of high priority in the rapidly aging population. Unfortunately, vaccine responses in the elderly are frequently diminished. Timely vaccination of middle-aged adults might improve the immune responses to vaccines, although knowledge on pathogen-specific immune responses and factors affecting these responses, in middle-aged adults is currently limited. We thus investigated the immune responses after vaccination with Zostavax consisting of live-attenuated varicella zoster virus (VZV)...
2018: Frontiers in Immunology
https://read.qxmd.com/read/27364410/virus-reactivations-after-autologous-hematopoietic-stem-cell-transplantation-detected-by-multiplex-pcr-assay
#18
JOURNAL ARTICLE
Natsuko Inazawa, Tsukasa Hori, Masanori Nojima, Makoto Saito, Keita Igarashi, Masaki Yamamoto, Norio Shimizu, Yuko Yoto, Hiroyuki Tsutsumi
Several studies have indicated that viral reactivations following allogeneic hematopoietic stem cell transplantation (allo-HSCT) are frequent, but viral reactivations after autologous HSCT (auto-HSCT) have not been investigated in detail. We performed multiplex polymerase chain reaction (PCR) assay to examine multiple viral reactivations simultaneously in 24 patients undergoing auto-HSCT between September 2010 and December 2012. Weekly whole blood samples were collected from pre- to 42 days post-HSCT, and tested for the following 13 viruses; herpes simplex virus 1 (HSV-1), HSV-2, varicella-zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), HHV-7, HHV-8, adeno virus (ADV), BK virus (BKV), JC virus (JCV), parvovirus B19 (B19V), and hepatitis B virus (HBV)...
February 2017: Journal of Medical Virology
https://read.qxmd.com/read/27322481/safety-and-immunogenicity-of-the-recombinant-bcg-vaccine-aeras-422-in-healthy-bcg-na%C3%A3-ve-adults-a-randomized-active-controlled-first-in-human-phase-1-trial
#19
RANDOMIZED CONTROLLED TRIAL
Daniel F Hoft, Azra Blazevic, Asmir Selimovic, Aldin Turan, Jan Tennant, Getahun Abate, John Fulkerson, Daniel E Zak, Robert Walker, Bruce McClain, Jerry Sadoff, Judy Scott, Barbara Shepherd, Jasur Ishmukhamedov, David A Hokey, Veerabadran Dheenadhayalan, Smitha Shankar, Lynn Amon, Garnet Navarro, Rebecca Podyminogin, Alan Aderem, Lew Barker, Michael Brennan, Robert S Wallis, Anne A Gershon, Michael D Gershon, Sharon Steinberg
BACKGROUND: We report a first-in-human trial evaluating safety and immunogenicity of a recombinant BCG, AERAS-422, over-expressing TB antigens Ag85A, Ag85B, and Rv3407 and expressing mutant perfringolysin. METHODS: This was a randomized, double-blind, dose-escalation trial in HIV-negative, healthy adult, BCG-naïve volunteers, negative for prior exposure to Mtb, at one US clinical site. Volunteers were randomized 2:1 at each dose level to receive a single intradermal dose of AERAS-422 (>10(5)-<10(6)CFU=low dose, ≥10(6)-<10(7)CFU=high dose) or non-recombinant Tice BCG (1-8×10(5)CFU)...
May 2016: EBioMedicine
https://read.qxmd.com/read/26725744/monitoring-of-epstein-barr-virus-ebv-cytomegalovirus-cmv-varicella-zoster-virus-vzv-load-in-patients-receiving-tocilizumab-for-rheumatoid-arthritis
#20
JOURNAL ARTICLE
Cindy Mourgues, Cecile Henquell, Zuzana Tatar, Bruno Pereira, Cinthya Nourisson, Anne Tournadre, Martin Soubrier, Marion Couderc
INTRODUCTION: IL-6 is involved in viral immunosurveillance. We studied the effect of tocilizumab (TCZ) on the evolution in viral load (VL) for the Epstein-Barr virus (EBV), cytomegalovirus (CMV) and varicella-zoster virus (VZV) in patients with rheumatoid arthritis (RA). METHODS: EBV, CMV and VZV loads were prospectively determined in whole blood of 22 RA patients at TCZ initiation and during treatment follow-up. A difference of 0.5 log10 or of threefold copies/mL between two VL was considered significant...
July 2016: Joint, Bone, Spine: Revue du Rhumatisme
keyword
keyword
52418
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.